Search details
1.
Phase II clinical trial of one dose of post-transplant cyclophosphamide for graft versus host disease prevention following myeloablative, peripheral blood stem cell, matched-unrelated donor transplantation.
Am J Hematol
; 96(10): E396-E398, 2021 10 01.
Article
in English
| MEDLINE | ID: mdl-34288026
Results
1 -
1
de 1
1
Next >
>>